Formulary
When prescribing inhalers the drug, device (e.g. MDI, Easibreathe, Autohaler, Accuhaler), strength (micrograms per inhalation), number of puffs per dose and frequency MUST be specified
Dry Powder Inhalers (DPIs) are, where clinically appropriate, the preferred devices to be used. In COPD combination inhalers should be used wherever possible.
| Glycopyrronium / Formoterol |
|
Formulary
|
Bevespi Aerosphere 7.2 micrograms glycopyrronium /5 micrograms formoterol pressurised inhalation, suspension Licensed for COPD only |
|
| Glycopyrronium / Indacaterol |
|
Formulary
|
Ultibro Breezhaler 85 micrograms indacaterol /43 micrograms glycopyrronium inhalation powder hard capsules Licensed for COPD only |
|
|
| Tiotropium bromide / Olodaterol |
|
Formulary
|
Spiolto Respimat 2.5 microgram tiotropium /2.5 microgram olodaterol inhalation solution Licensed for COPD only |
|
|
| Umeclidinium bromide / Vilanterol |
|
Formulary
|
Anoro Ellipta 55 micrograms umeclidinium /22 micrograms vilanterol inhalation powder, pre-dispensed Licensed for COPD only |
|
|
Links
NICE TA10: Guidance on the use of inhaler systems (devices) in children under the age of 5 years with chronic asthma
Asthma action plan child: Asthma UK- Asthma management plan: Asthma UK
- LSCMMG: Asthma Treatment Guideline for Adults
- LSCMMG: Asthma Treatment Guideline for Children
- LSCMMG: Chronic Obstructive Pulmonary Disease (COPD) Desktop Guideline
- LSCMMG: Chronic Obstructive Pulmonary Disease (COPD) Desktop Guideline
- MART asthma plan
- MHRA Drug Safety Update :Nebulised asthma rescue therapy in children: home use of nebulisers in paediatric asthma should be initiated and managed only by specialists
- MHRA: Pressurised metered dose inhalers (pMDI): risk of airway obstruction from aspiration of loose objects
- NICE New Medicine Evidence Summary 33: indacaterol/glycopyrronium (Ultibro Breezhaler)
- NICE NG115: Chronic obstructive pulmonary disease in over 16s: diagnosis and management
- NICE NG209: Tobacco: preventing uptake, promoting quitting and treating dependence
- NICE NG80:Asthma: diagnosis, monitoring and chronic asthma management
- NICE TA347: Nintedanib for previously treated locally advanced, metastatic, or locally recurrent non‑small‑cell lung cancer
- NICE TA38: Inhaler devices for routine treatment of chronic asthma in older children (aged 5–15 years)